Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism

Neuroscience Letters

Volumn 402, Issue 3, 2006, Pages 262-266

  von Trotha, K T ^a   Heun, R ^a   Schmitz, S ^a   Lutjohann D ^a   Maier, W ^a   Kolsch H ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Alzheimer's disease; Association; Chromosome 10; Lysosomal acid lipase (LIPA); Polymorphism

Indexed keywords

ACID LIPASE; CHOLESTEROL DERIVATIVE;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHROMOSOME 10; CONTROLLED STUDY; EXON; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLESTEROL; CHOLESTEROL ESTERASE; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK;

EID: 33744900089     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.04.009     Document Type: Article

References (32)

1. Anderson R.A., Byrum R.S., Coates P.M., and Sando G.N. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2718-2722
2. Aslanidis C., Klima H., Lackner K.J., and Schmitz G. Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics 20 (1994) 329-331
3. Ball M.J. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol. (Berl.) 37 (1977) 111-118
4. Becker T., and Knapp M. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am. J. Hum. Genet. 75 (2004) 561-570
5. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M.G., Go R.C., Vekrellis K., Selkoe D.J., Saunders A.J., and Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290 (2000) 2302-2303
6. Blacker D., Bertram L., Saunders A.J., Moscarillo T.J., Albert M.S., Wiener H., Perry R.T., Collins J.S., Harrell L.E., Go R.C., Mahoney A., Beaty T., Fallin M.D., Avramopoulos D., Chase G.A., Folstein M.F., McInnis M.G., Bassett S.S., Doheny K.J., Pugh E.W., Tanzi R.E., and NIMH Genetics Initiative Alzheimer's Disease Study Group. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum. Mol. Genet. 12 (2003) 23-32
7. Bretillon L., Siden A., Wahlund L.O., Lütjohann D., Minthon L., Crisby M., Hillert J., Groth C.G., Diczfalusy U., and Bjorkhem I. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci. Lett. 293 (2000) 87-90
8. Dupuy A.M., Mas E., Ritchie K., Descomps B., Badiou S., Cristol J.P., and Touchon J. The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease. Gerontology 47 (2001) 213-218
9. Dzeletovic S., Breuer O., Lund E., Givel F., Helftenbein G., and Wahli W. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225 (1995) 73-80
10. Fassbender K., Simons M., Bergmann C., Stroick M., Lütjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., and Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5856-5961
11. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 12 (1975) 189-198
12. St. George-Hyslop P.H. Molecular genetics of Alzheimer's disease. Biol. Psychiatry 47 (2000) 183-199
13. Hamajima N., Saito T., Matsuo K., Kozaki K., Takahashi T., and Tajima K. Polymerase chain reaction with confronting two-pair primers for polymerase genotyping. Jpn. J. Cancer Res. 91 (2000) 865-868
14. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 256 (1992) 184-185
15. Henderson A.S., Easteal S., Jorm A.F., Mackinnon A.J., Korten A.E., Christensen H., Croft L., and Jacomb P.A. Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet 346 (1995) 1387-1390
16. Jick H., Zornberg G.L., Jick S.S., Seshadri S., and Drachmann D.A. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
17. Kehoe P., Wavrant-De Vrieze F., Crook R., Wu W.S., Holmans P., Fenton I., Spurlock G., Norton N., Williams H., Williams N., Lovestone S., Perez-Tur J., Hutton M., Chartier-Harlin M.C., Shears S., Roehl K., Booth J., Van Voorst W., Ramic D., Williams J., Goate A., Hardy J., and Owen M.J. A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8 (1999) 237-245
18. Kivipelto M., Helkala E.L., Laakso M.P., Hanninen T., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., and Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 (2001) 1447-1451
19. Kölsch H., Heun R., Kerksiek A., von Bergmann K., Maier W., and Lütjohann D. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 368 (2004) 303-308
20. Kukull W.A., Schellenberg G.D., Bowen J.D., McCormick W.C., Yu C.E., Teri L., Thompson J.D., O'Meara E.S., and Larson E.B. Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study. J. Clin. Epidemiol. 49 (1996) 1143-1148
21. Li G., Higdon R., Kukull W.A., Peskind E., van Valen Moore K., Tsuang D., van Belle G., McCormick W., Bowen J.D., Teri L., Schellenberg G.D., and Larson E.B. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 63 (2004) 1624-1628
22. Lütjohann D., and von Bergmann K. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 36 (2003) 102-106
23. Lütjohann D., Papassotiropoulos A., Björkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von Bergmann K., and Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patiens. J. Lipid Res. 41 (2000) 195-198
24. Martins R.N., Clarnette R., Fisher C., Broe G.A., Brooks W.S., Montgomery P., and Gandy S.E. ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport 6 (1995) 1513-1516
25. Myers A., Holmans P., Marshall H., Kwon J., Meyer D., Ramic D., Shears S., Booth J., DeVrieze F.W., Crook R., Hamshere M., Abraham R., Tunstall N., Rice F., Carty S., Lillystone S., Kehoe P., Rudrasingham V., Jones L., Lovestone S., Perez-Tur J., Williams J., Owen M.J., Hardy J., and Goate A.M. Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290 (2000) 2304-2305
26. Myers A., Wavrant De-Vrieze F., Holmans P., Hamshere M., Crook R., Compton D., Marshall H., Meyer D., Shears S., Booth J., Ramic D., Knowles H., Morris J.C., Williams N., Norton N., Abraham R., Kehoe P., Williams H., Rudrasingham V., Rice F., Giles P., Tunstall N., Jones L., Lovestone S., Williams J., Owen M.J., Hardy J., and Goate A. Full genome screen for Alzheimer disease: stage II analysis. Am. J. Med. Genet. (Neuropsychiatry Genet.) 114 (2002) 235-244
27. Notkola I.L., Sulkava R., Pekkanen J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., and Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17 (1998) 14-20
28. Papassotiropoulos A., Wollmer M.A., Tsolaki M., Brunner F., Molyva D., Lütjohann D., Nitsch R.M., and Hock C. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J. Clin. Psychiatry 66 (2005) 940-947
29. Riemenschneider M., Mahmoodzadeh S., Eisele T., Klopp N., Schwarz S., Wagenpfeil S., Diehl J., Mueller U., Foerstl H., Illig T., and Kurz A. Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease. Neurobiol. Aging 25 (2004) 1305-1308
30. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., and Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6460-6464
31. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., and Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 1977-1981
32. Wolozin B., Kellman W., Rousseau P., Celesia G.G., and Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arch. Neurol. 57 (2000) 1439-1443